You are here
Mekanistic Therapeutics, LLC
UEI: LSULPAHTNHN7
# of Employees: 2
HUBZone Owned: No
Socially and Economically Disadvantaged: Yes
Woman Owned: Yes
Award Charts
Award Listing
-
Development of Novel Therapeutic Molecules for Treatment of Squamous Head and Neck Cancers
Amount: $449,111.00Mekanistic Therapeutics seeks to design, discover, and develop anti-cancer agents that selectively inhibit multiple oncogenic pathways. Among Mekanistic’s portfolio are dual and highly selective inh ...
STTRPhase I2021Department of Health and Human Services National Institutes of Health -
Development of MTX-211 for the Treatment of KRAS Mutant Colorectal Cancer
Amount: $1,861,575.00PROJECT SUMMARY Mekanistic Therapeutics seeks to design, discover, and develop anti-cancer agents that selectively inhibit multiple oncogenic pathways. Its lead agent MTX-211 was discovered in collabo ...
SBIRPhase II2019Department of Health and Human Services National Institutes of Health -
Development of MTX for the Treatment of KRAS Mutant Colorectal Cancer
Amount: $275,000.00PROJECT SUMMARY Mekanistic Therapeutics seeks to design discover and develop anti cancer agents that selectively inhibit multiple oncogenic pathways Its lead agent MTX was discovered in collabo ...
STTRPhase I2017Department of Health and Human Services National Institutes of Health